|
Jul 14
|
Alligator Bioscience Comments on Henlius Dosing First Patient in the US in Phase 3 Trial of HLX22 in Gastric Cancer
|
|
Aug 27
|
High Growth Tech Stocks In Hong Kong To Watch
|
|
Jan 11
|
Henlius and Sermonix Announce Strategic Collaboration and Exclusive License Agreements for Novel Endocrine Therapy Lasofoxifene
|
|
Dec 28
|
HANSIZHUANG Sets Sail in Indonesia Market
|
|
Aug 25
|
Henlius 2023 H1 Results: Achieved record profits and RMB2.5 billion revenues, opening a new chapter of high-quality growth
|